Related references
Note: Only part of the references are listed.Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis
Edward Keystone et al.
ARTHRITIS AND RHEUMATISM (2007)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss
F. Van Wijk et al.
AUDIOLOGY AND NEURO-OTOLOGY (2006)
Rituximab treatment in patients with primary Sjogren's syndrome
J Pijpe et al.
ARTHRITIS AND RHEUMATISM (2005)
Etanercept treatment for autoimmune inner ear disease: Results of a pilot placebo-controlled study
S Cohen et al.
OTOLOGY & NEUROTOLOGY (2005)
Etanercept therapy for immune-mediated cochleovestibular disorders: A multi-center, open-label, pilot study
EL Matteson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss
TS Nair et al.
JOURNAL OF NEUROSCIENCE (2004)
Immune-mediated inner ear disease: 10-year experience
SS Broughton et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate - A randomized controlled trial
JP Harris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Treatment of IgM antibody associated polyneuropathies using rituximab
A Pestronk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
JH Anolik et al.
ARTHRITIS AND RHEUMATISM (2003)
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia
N Gupta et al.
LEUKEMIA (2002)
To the editor: Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2002)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
Use of methotrexate for autoimmune hearing loss
O Tirzaman et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2000)
Share Paper
